CLINICAL_TRIALS
trial_result
· 2017-12-20
Clinical Trial Update: Trial of Sunitinib for Refractory Malignant Ascites [Phase 2]
Summary
Phase 2 trial update for sunitinib in refractory malignant ascites has been terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Milton S. Hershey Medical Center | Conditions: Ascites | Phase 2 | Status: TERMINATED | Results posted: 2017-12-20